Richard Schroeder is a Sr. Principal Biologist in Diabetes Complications & Outcomes Research at Eli Lilly and Company, where they focus on cardiovascular, renal, and related metabolic diseases. Their extensive research background includes roles as a Senior Research Scientist at RxGen Inc. and Team Lead for In Vivo Physiology and Pharmacology at Moderna Therapeutics. Richard has developed expertise in preclinical models, particularly in evaluating cardiac and metabolic disease conditions through various laboratory settings. Their previous experience spans multiple prestigious organizations, including Pfizer Pharmaceuticals and Covance Laboratories. Richard is dedicated to providing highly translatable models for the research community.
This person is not in any teams
This person is not in any offices